These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36150542)

  • 41. Hyperlipidemia induces meibomian gland dysfunction.
    Bu J; Wu Y; Cai X; Jiang N; Jeyalatha MV; Yu J; He X; He H; Guo Y; Zhang M; Quantock AJ; Liu Z; Li W
    Ocul Surf; 2019 Oct; 17(4):777-786. PubMed ID: 31201956
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [An experimental study on the reverse mechanism of PPAR-gamma agonist rosiglitazone in rats with non-alcoholic steatohepatitis].
    Zhao CY; Wang YD; Zhou JY; Jia B; Cui JF
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jun; 15(6):450-5. PubMed ID: 17594812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decreased hepatic peroxisome proliferator-activated receptor-γ contributes to increased sensitivity to endotoxin in obstructive jaundice.
    Lv X; Song JG; Li HH; Ao JP; Zhang P; Li YS; Song SL; Wang XR
    World J Gastroenterol; 2011 Dec; 17(48):5267-73. PubMed ID: 22219595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-Fat Diet Induces Inflammation of Meibomian Gland.
    Bu J; Zhang M; Wu Y; Jiang N; Guo Y; He X; He H; Jeyalatha MV; Reinach PS; Liu Z; Li W
    Invest Ophthalmol Vis Sci; 2021 Aug; 62(10):13. PubMed ID: 34398199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Agonist of peroxisome proliferator-activated receptor-gamma, rosiglitazone, reduces renal injury and dysfunction in a murine sepsis model.
    Lee S; Kim W; Kang KP; Moon SO; Sung MJ; Kim DH; Kim HJ; Park SK
    Nephrol Dial Transplant; 2005 Jun; 20(6):1057-65. PubMed ID: 15797891
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
    Celinski K; Dworzanski T; Korolczuk A; Piasecki R; Slomka M; Madro A; Fornal R
    J Physiol Pharmacol; 2011 Jun; 62(3):347-56. PubMed ID: 21893696
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 15-Deoxy-Δ(12,14)-prostaglandin J(2) modulates lipopolysaccharide-induced chemokine expression by blocking nuclear factor-κB activation via peroxisome proliferator activated receptor-γ-independent mechanism in renal tubular epithelial cells.
    Lu Y; Zhou Q; Zhong F; Guo S; Hao X; Li C; Wang W; Chen N
    Nephron Exp Nephrol; 2013; 123(1-2):1-10. PubMed ID: 23887394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes.
    Massaro M; Scoditti E; Pellegrino M; Carluccio MA; Calabriso N; Wabitsch M; Storelli C; Wright M; De Caterina R
    Pharmacol Res; 2016 May; 107():125-136. PubMed ID: 26976796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
    Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
    Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor agonists synergistically suppress proliferation of immortalized endometrial stromal cells.
    Wu Y; Guo SW
    Fertil Steril; 2009 May; 91(5 Suppl):2142-7. PubMed ID: 18571164
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Maffia P; Patel NS; Di Paola R; Ialenti A; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Eur J Pharmacol; 2004 Jan; 483(1):79-93. PubMed ID: 14709329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IL-10 mediates rosiglitazone-induced kidney protection in cisplatin nephrotoxicity.
    Kim MG; Yang HN; Kim HW; Jo SK; Cho WY; Kim HK
    J Korean Med Sci; 2010 Apr; 25(4):557-63. PubMed ID: 20357998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eicosapentaenoic acid (EPA) activates PPARγ signaling leading to cell cycle exit, lipid accumulation, and autophagy in human meibomian gland epithelial cells (hMGEC).
    Kim SW; Rho CR; Kim J; Xie Y; Prince RC; Mustafa K; Potma EO; Brown DJ; Jester JV
    Ocul Surf; 2020 Jul; 18(3):427-437. PubMed ID: 32360782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibitory effects of rosiglitazone on lipopolysaccharide-induced inflammation in a murine model and HK-2 cells.
    Wang WM; Chen H; Zhong F; Lu Y; Han L; Chen N
    Am J Nephrol; 2011; 34(2):152-62. PubMed ID: 21734368
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
    Kim MJ; Deplewski D; Ciletti N; Michel S; Reichert U; Rosenfield RL
    Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of PPAR Ligands as Modulators of Resolution of Inflammation, via Their Influence on Cytokines and Oxylipins Release in Astrocytes.
    Chistyakov DV; Astakhova AA; Goriainov SV; Sergeeva MG
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The influence of 13-cis retinoic acid on human meibomian gland epithelial cells.
    Ding J; Kam WR; Dieckow J; Sullivan DA
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4341-50. PubMed ID: 23722388
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PPAR-
    Meng QQ; Feng ZC; Zhang XL; Hu LQ; Wang M; Zhang HF; Li SM
    Mediators Inflamm; 2019; 2019():6386729. PubMed ID: 31015796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of peroxisome proliferator-activated receptor-gamma potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge.
    Liu Y; Shi J; Lu J; Meng G; Zhu H; Hou Y; Yin Y; Zhao S; Ding B
    Innate Immun; 2009 Jun; 15(3):169-78. PubMed ID: 19474210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.